Presentations highlight clinically meaningful reductions in BMI in patients with acquired hypothalamic obesity - ...

Rhythm Pharmaceuticals shares surged to a record high Wednesday on promising results for a drug that could treat a rare form ...

The new Temple Women and Families Hospital near Juniata Park will handle nearly all health system labor and deliveries, as ...

Rhythm Pharmaceuticals’ push to move obesity patients from jabs to tabs has stayed on beat. | Rhythm Pharmaceuticals’ push to ...

Rhythm Pharmaceuticals, Inc. (RYTM) shares rallied 36.6% in the last trading session to close at $89. This move can be attributable to notable volume with a higher number of shares being traded than ...

Rhythm Pharmaceuticals' potential first-in-class HO drug, strong pipeline, and limited competition offer blockbuster potential. Click to read why RYTM is a Buy.

Rhythm Pharmaceuticals' experimental drug helped patients with a rare form of obesity caused by brain damage cut weight in a small study, the drugmaker said on Monday, sending its shares 24% higher in ...

The Chicago Human Rhythm Project is celebrating 35 years of rhythm, culture and community with Rhythm World, a weeklong ...

Dum is a mesmerizing auditory journey crafted by rhythm maestros Bickram Ghosh and Taufiq Qureshi. This avant-garde piece ...

Rhythm said results of the recent trial were also consistent with BMI reductions achieved with setmelanotide therapy in similar patient populations in past trials. Setmelanotide, an existing ...